Boston blog main / Boston top stories / Boulder / Denver blog main / Denver top stories / Detroit blog main / Detroit top stories / Indiana blog main / Indiana top stories / National blog main / National top stories / New York blog main / New York top stories / Raleigh-Durham blog main / Raleigh-Durham top stories / San Diego blog main / San Diego top stories / San Francisco / San Francisco blog main / San Francisco top stories / Seattle blog main / Seattle top stories / Texas blog main / Texas top stories / Wisconsin blog main / Wisconsin top stories / Adaptive Insights / Allogene Therapeutics / Anaplan / Box / Data Analytics / deals / Del Monte / DFJ Growth / DocuSign / enterprise software / Entrepreneurship / Equillium / Eventbrite / financial planning and analysis software / Financing / funding / Granite Ventures / HP / IBM / initial public offering / innovation / Internet / Investor / IPO / IT / Kepion / Livent / McAfee / Meritech Capital Partners / oracle / Osmotica Pharmaceuticals / Premji Invest / SanFranciscoVC / sap / Shasta Ventures / Software / startups / Top Tier Capital Partners / United Airlines / Upwork / VC / Vena Solutions / Venture Capital / Web / Web-based Software / Workday

Anaplan Ups Estimate For Its IPO Haul; Allogene IPO Raises $288M

Posted on: Oct 11, 2018   |   Posted by: Biotech Mag

Anaplan Ups Estimate For Its IPO Haul; Allogene IPO Raises $288M

San Francisco-based Anaplan , one of five companies planning to close initial public offerings this week, raised the expected price range for its shares in an SEC filing...

Continue reading ...